GLP-1 Analytical Workflows banner
29 JULY 2026

Waters: How Top Labs Think About GLP-1 Analytical Workflows

Accelerate GLP-1 drug development with confidence

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are transforming therapeutic development — and analytical teams are under pressure to keep pace with increasing demand, complex peptide profiles, and high-quality expectations. From discovery through commercial quality control (QC), the choices you make up front can impact speed, reproducibility, and regulatory confidence.

Whether you’re just starting to evaluate your analytical approach or looking to optimize existing workflows, having a clear view of the full GLP-1 workflow landscape is essential.

Discover how leading teams:

  • Navigate GLP-1 analysis across development and manufacturing
  • Achieve high-quality, reproducible data that supports confident decision-making
  • Reduce analytical uncertainty and accelerate time to market
  • Build regulatory-ready methods that scale from characterization to QC and release testing

Explore GLP-1 Solutions

Follow the link to Browse Products →